These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7268117)

  • 1. [Urinary excretion of calcium, magnesium and uric acid in kidney stone patients, their asymptomatic relatives and healthy subjects].
    González-Calvin JL; Montero García M; García Valdecasas J; Luna J; Raya Muñoz J; Peña Angulo JF; Peña Yáñez A
    Rev Clin Esp; 1981 Feb; 160(4):247-50. PubMed ID: 7268117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sex specific factors in recurrent idiopathic calcium urolithiasis].
    Weitbrecht M; Hegemann M; Pfab R; Wieser T
    Urologe A; 1987 May; 26(3):129-32. PubMed ID: 3603898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a risk for kidney stone formation in cystic fibrosis?
    Böhles H; Michalk D
    Helv Paediatr Acta; 1982 Jun; 37(3):267-72. PubMed ID: 7118558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct titrimetric determination of uric acid separately and in urine of patients containing stone.
    Shyam H; Saxena OC
    Ital J Biochem; 1973; 22(2):65-73. PubMed ID: 4771416
    [No Abstract]   [Full Text] [Related]  

  • 6. Circadian variations of blood and urinary constituents in renal stone formers.
    Singh RK; Bansal A; Bansal SK; Rai SP
    Prog Clin Biol Res; 1990; 341B():551-7. PubMed ID: 2217342
    [No Abstract]   [Full Text] [Related]  

  • 7. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary magnesium excretion in nephrolithiasis].
    Simeonov S; Dimitrakova D; Kumchev E
    Vutr Boles; 1988; 27(6):39-43. PubMed ID: 3247702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease.
    Mente A; Honey RJ; McLaughlin JM; Bull SB; Logan AG
    J Am Soc Nephrol; 2006 Sep; 17(9):2567-75. PubMed ID: 16855017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of inhibitors of calcification in urine. Part I. Findings in control subjects and patients with renal stones.
    Oreopoulos DG; Walker D; Akriotis DJ; Roncari DA; Husdan H; Symvoulidis A; Deveber GA; Rapoport A; Reid DB
    Can Med Assoc J; 1975 Apr; 112(7):827-31. PubMed ID: 1122457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium cellulose phosphate-induced increment in urinary calcium/magnesium ratio.
    Revusova V; Gratzlova J; Zvara V; Kridl J; Landsmanova L
    Eur Urol; 1975; 1(6):294-6. PubMed ID: 1233199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in some risk factors and urinary enzymes in urolithiatic rats treated with sodium pentosan polysulphate.
    Subha K; Varalakshmi P
    Biochem Mol Biol Int; 1993 Feb; 29(2):271-80. PubMed ID: 7684293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrolyte excretion of patients with kidney stones].
    Götz F; Váry L; Kelemen Z
    Z Urol Nephrol; 1969 Jan; 62(1):23-8. PubMed ID: 4247405
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary stone risk factors in the siblings of patients with calcium renal stones.
    Kinder JM; Clark CD; Coe BJ; Asplin JR; Parks JH; Coe FL
    J Urol; 2002 May; 167(5):1965-7. PubMed ID: 11956418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of relative hypomagnesurea in calcium lithiasis: reference values for a new parameter].
    Labeeuw M; Pozet N; Gerbaulet C; Zech P; Traeger J
    Nephrologie; 1984; 5(3):101-5. PubMed ID: 6493428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the physicochemical risk for renal stone disease during pregnancy.
    Smith CL; Kristensen C; Davis M; Abraham PA
    Clin Nephrol; 2001 Mar; 55(3):205-11. PubMed ID: 11316240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the stone former.
    Burns JR; Finlayson B
    Semin Urol; 1984 Feb; 2(1):34-44. PubMed ID: 6463460
    [No Abstract]   [Full Text] [Related]  

  • 19. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urinary calcium-magnesium ratio in calcigerous stone formers.
    King JS; O'Connor FJ; Smith MJ; Crouse L
    Invest Urol; 1968 Jul; 6(1):60-5. PubMed ID: 5663560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.